FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Cipla Phytonadione Injectable Emulsion Recall

Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only…

Cipla Limited

Risk level
Class II
Reported by FDA
Dec 10, 2025
Recall ID
D-0197-2026
Check your lot numberHow we source this data

Summary

Cipla recalled Phytonadione Injectable Emulsion starting Oct 31, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0197-2026 on Dec 10, 2025. Reason: Failed Stability Specifications: Observed OOS results: eg results for colour index. Status: Ongoing.

Why it was recalled

Failed Stability Specifications: Observed OOS results: eg results for colour index

Product description

Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96

Lot numbers, UPCs & expiration codes

Batch # PH0072404A, PH0082404A, Exp. Date December 31, 2025

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0197-2026
Classification
Class II
Status
Ongoing
Recall initiated
Oct 31, 2025
FDA report date
Dec 10, 2025
Quantity
4,438 10x1mL cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Cipla Limited

Original FDA data

Every field from FDA enforcement report D-0197-2026, exactly as published.

Show all FDA fields
City
Pithampur, District Dhar
Status
Ongoing
Country
India
Event ID
97909
Address
Plot No. 9 & 10, Pharma Zone Phase Ii
Address (line 2)
Section Iiii, Indore Special Economic Zone
Code information
Batch # PH0072404A, PH0082404A, Exp. Date December 31, 2025
Report date
Dec 10, 2025
Product type
Drugs
Recall number
D-0197-2026
Classification
Class II
Recalling firm
Cipla Limited
Product quantity
4,438 10x1mL cartons
Reason for recall
Failed Stability Specifications: Observed OOS results: eg results for colour index
Voluntary / mandated
Voluntary: Firm initiated
Product description
Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 31, 2025
Center classification date
Nov 28, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0197-2026, published Dec 10, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls